Inactive Instrument

Amylin Pharmaceuticals LLC Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

02/12/02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
17/12/17	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

02/12/02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
17/12/17	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/12/16	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/12/15	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
11/12/11	Forest Laboratories, Inc. : Exclusive: Icahn offered to settle with Forest before battle	RE
10/12/10	Exclusive: Icahn offered to settle with Forest before battle	RE
03/12/03	SANOFI : Icahn return on Amylin tops 35 percent	RE
03/12/03	Bristol Myers Squibb Co. : Bristol's patent woes persist despite Amylin buy	RE
30/12/30	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
30/12/30	SANOFI : Bristol-Myers to buy Amylin for about $5.3 billion	RE
02/12/02	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE
01/12/01	Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	RE
26/12/26	Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	RE

09/12/09	Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	PU
12/12/12	Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation	BU
09/12/09	Amylin Pharmaceuticals, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.	PR
07/12/07	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	BU
04/12/04	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	PR

16/12/16	GSK annonce le rachat de Human Genome pour $3,0 milliards
03/12/03	Wall Street termine sans grande tendance après les PMI
02/12/02	USA-Les valeurs à suivre à Wall Street
30/12/30	Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin
31/12/31	Sanofi veut élargir son offre sur le marché du diabète

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+0.61%	+3.43%	+41.41%	+0.28%	8.27TCr
CSL LIMITED	+2.68%	+29.00%	-19.83%	-34.19%	5.79TCr
MODERNA, INC.	+14.36%	+146.40%	+485.66%	+40.99%	5.54TCr
SAMSUNG BIOLOGICS CO.,LTD.	+0.76%	+2.39%	+0.08%	+35.11%	5.26TCr
UCB	+1.86%	+4.04%	+13.58%	+175.04%	4.89TCr
BIOGEN INC.	+1.21%	+5.56%	+58.47%	-15.87%	3.22TCr
INCYTE CORPORATION	+1.36%	+5.04%	+52.54%	+101.96%	2.59TCr
INNOVENT BIOLOGICS, INC.	+0.60%	+4.98%	+0.65%	+188.89%	2.21TCr
SWEDISH ORPHAN BIOVITRUM AB	+3.89%	+2.58%	+61.60%	+116.01%	1.65TCr
Average	+2.94%	+17.75%	+77.13%	+67.58%	4.38TCr
Weighted average by Cap.	+3.15%	+21.99%	+86.59%	+48.06%

Employees

Sector